CASE STUDIES

How Apogee Therapeutics consolidated 15 legal entities under one NetSuite environment with the Archer AI Approval Module, JPM Fispan banking integration, and audit ready trails configured for IPO scrutiny.

This case study highlights how a multi-entity specialty pharmacy, struggled with fragmented systems that made consolidation slow, manual, and unreliable. It shows how NetSuite, implemented by Archer Insights, unified all entities into a single system—automating intercompany eliminations and enabling real-time, accurate financial reporting.

This case study shows how a clinical-stage biopharma company relied on QuickBooks and manual processes for managing complex CRO accruals and financial close, leading to audit challenges and inefficiencies. It highlights how NetSuite, implemented by Archer Insights, automated accruals, standardized approvals, and accelerated the close—resulting in an audit-ready, scalable financial system.

This case study shows how Archer Insights moved a medical device manufacturer from manual expense tracking and undocumented approvals to a governed NetSuite environment built for SOX controls and Sunshine Act reporting, then extended that system through ongoing managed support.

How a NASDAQ-listed clinical-stage cardiopulmonary biopharma moved from QuickBooks, Microsoft Word purchase orders, and manual month-end close to a governed NetSuite environment with vendor management, controlled procure-to-pay, integrated banking, and comprehensive process documentation.

This case study shows how Acorda Therapeutics transformed a manual, paper-based AP process into a fully automated, paperless procure-to-pay system. By implementing NetSuite with Archer Insights, they streamlined approvals, enforced contract controls, and gained real-time cash visibility—resulting in improved efficiency, audit readiness, and financial control.

How Eupraxia Pharmaceuticals moved approvals and reporting into NetSuite as the source of truth, returning 50 to 65 percent of monthly reporting time to its finance team across 8 subsidiaries.

This case study shows how Hepion Pharmaceuticals, a NASDAQ-listed biopharma company, outgrew Sage 50 and Bill.com, leading to recurring audit issues and manual financial processes. It highlights how NetSuite, implemented by Archer Insights, replaced both systems with a single, audit-ready platform—automating controls, consolidations, and payments while improving accuracy and compliance.

This case study shows how Strive Pharmacy, a rapidly expanding multi-location compounding pharmacy, struggled with fragmented QuickBooks systems that made consolidation and control difficult. It highlights how NetSuite, implemented by Archer Insights, unified all locations into a single system—automating consolidation, enforcing controls, and enabling real-time financial visibility to support scal

How Outlook Therapeutics selected NetSuite and went live with a public company controls posture while Archer Insights handled the heavy lifting and the internal team stayed focused on commercial launch readiness.

How Neogene Therapeutics scaled financial controls and cell therapy supply chain inside one NetSuite environment with Archer Insights, into the 2023 AstraZeneca acquisition.

How Aurinia Pharmaceuticals scales procurement automation and contract lifecycle management on NetSuite alongside a 283 million dollar commercial business in partnership with Archer Insights.

How Therakos migrated 14 countries from SAP to NetSuite OneWorld in 10 months, on time and under budget, into the operating model that supported a 925 million dollar sale to CVC.

How Affini-T Therapeutics closed recurring audit findings with the Archer AI Approval Module, locked master data, and automated fixed assets across hundreds of cell therapy lab instruments.